FDA
approval
· 2025-10-23
FDA Approved: DALBAVANCIN — Original Application (Teva Pharmaceuticals, Inc.)
Summary
FDA approved Teva's original ANDA for dalbavancin, allowing generic production of the antibiotic.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for DALBAVANCIN (DALBAVANCIN)